ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: FR-PO0160

Novel IC-IL33-Treg Axis in Kidney Immunosurveillance and Autoimmune Injury

Session Information

  • AKI: Mechanisms - 2
    November 07, 2025 | Location: Exhibit Hall, Convention Center
    Abstract Time: 10:00 AM - 12:00 PM

Category: Acute Kidney Injury

  • 103 AKI: Mechanisms

Authors

  • Avenatti, Maria Carolina, Program in Membrane Biology, Nephrology Division, Department of Medicine, Massachusetts General Hospital and Harvard Medical School., Boston, Massachusetts, United States
  • Elizagaray, Maia Lina, Program in Membrane Biology, Nephrology Division, Department of Medicine, Massachusetts General Hospital and Harvard Medical School., Boston, Massachusetts, United States
  • Barrachina, Ferran, Program in Membrane Biology, Nephrology Division, Department of Medicine, Massachusetts General Hospital and Harvard Medical School., Boston, Massachusetts, United States
  • Bastepe, Isinsu, Program in Membrane Biology, Nephrology Division, Department of Medicine, Massachusetts General Hospital and Harvard Medical School., Boston, Massachusetts, United States
  • Battistone, Maria A., Program in Membrane Biology, Nephrology Division, Department of Medicine, Massachusetts General Hospital and Harvard Medical School., Boston, Massachusetts, United States

Group or Team Name

  • Battistone Lab.
Background

Various autoimmune diseases are frequently associated with Acute Kidney Injury (AKI). The underlying patho-mechanisms are complex and varied, involving autoantibodies and cellular immune responses that mediate renal injury. Intercalated cells (ICs), which are involved in proton secretion in the renal tubules, may also be key players in initiating immune responses within the kidney. These cells are strategically positioned at the interface between the renal epithelial barrier and the immune system, making them well-suited to sense and respond to stress signals. This study explores the molecular mechanisms by which ICs communicate with immune cells to maintain renal immune homeostasis and contribute to autoimmune manifestations.

Methods

We depleted Foxp3+ regulatory T cells (Tregs) by injecting (i.p.) diphtheria toxin (DT) into male and female Foxp3-DTR mice. We analyzed, 2 weeks post-depletion, the renal immune responses using flow cytometry, ELISA of urine and serum autoantibodies, confocal microscopy, and functional kidney assessments. RNA sequencing of ICs was performed to identify molecular pathways.

Results

Treg depletion triggered autoimmune inflammatory responses characterized by aggravated immune cell infiltration (neutrophils, macrophages, T and B cells), formation of B cell clusters, and enhanced antigen presentation. We observed elevated renal IgG, IgM, IgA, IgG1, and IgG2c autoantibodies in urine and serum, and antibody deposition in glomeruli and around tubules. Kidney damage was evidenced by reduced glomeruli size, proximal tubular injury, increased urine albumin/creatinine ratio, and reduced urine output. Tolerance disruption induced IC upregulation of inflammasome-related genes and IL-33, a key alarmin that signals damage and activates tissue Tregs. Despite initial Treg depletion, we observed a notable Treg rebound with enhanced presence of activated CD69+ Tregs.

Conclusion

Our findings reveal novel positive IC-Treg crosstalk through the IL-33 pathway, identifying immunoregulatory mechanisms that maintain renal immune tolerance. The identification of a specific AKI subgroup and its molecular mechanisms offers potential targets for developing therapeutic strategies against autoimmune kidney injury.

Funding

  • Other NIH Support

Digital Object Identifier (DOI)